Krispy Kreme's quarterly earnings plunge

Catch up with NBC News Clone on today's hot topic: Wbna5827434 - Breaking News | NBC News Clone. Our editorial team reformatted this story for clarity and speed.

Once the darling of Wall Street, doughnut-maker Krispy Kreme on Thursday reported second-quarter profits that were more than 50 percent lower than a year ago and that widely missed analysts’ expectations.

Once the darling of Wall Street, doughnut-maker Krispy Kreme on Thursday reported second-quarter profits that were more than 50 percent lower than a year ago and that widely missed analysts’ expectations.

In years past, meeting or surpassing Wall Street’s expectations was nearly a foregone conclusion for the folks at Krispy Kreme, which went public amid much fanfare in 2000 and posted quarter after quarter of ever-increasing profits.

However, on Thursday the Winston-Salem-based company said it expects slower sales for the remainder of the year. And it declined to project its earnings for the third quarter or for 2005.

“Although we are disappointed with the second-quarter financial results, we are optimistic about the long-term growth potential of the business,” said chief executive CEO Scott Livengood.

Krispy Kreme earned $5.7 million, or 9 cents per share, in its second quarter, compared with $13 million, or 21 cents per share, a year earlier.

Excluding discontinued operations and other items, the company posted earnings of $7.3 million, or 12 cents per share, in the latest quarter. This widely missed analyst expectations of profits of 22 cents per share, according to Thomson First Call.

Total sales rose $177.4 million, up 11.5 percent, in the second quarter. On a comparable-store basis, systemwide sales were up 0.1 percent and company store sales rose 0.6 percent, the company said.

Sales growth outlook cut
Krispy Kreme also said it was reducing its 2005 system-wide sales growth guidance to about 15 percent. It also said it would not provide earnings guidance for the third quarter and is no longer making a projection for the year.

Wall Street’s judgment was swift and harsh in May, when Krispy Kreme’s chief executive officer blamed lower sales and the company’s first-ever quarterly loss on the low-carb diet craze that was sweeping the nation. Krispy Kreme said it lost $24.4 million in the first quarter.

Shares plummeted, stores were closed, shareholders sued and executives recently confirmed that Krispy Kreme is the subject of an “informal, nonpublic inquiry” by the Securities and Exchange Commission on its franchise reacquisitions and its future earnings guidance.

Also recently, the company announced the departure of chief financial officer John Tate.

Despite all the challenges, the company’s shares have risen over the past week, from a near four-year low of $12.80 on Aug. 17 to a close at $15.36 on Wednesday.

Steven Clark, an assistant professor of finance at the Belk College of Business at the University of North Carolina at Charlotte, said the company has been a victim of its own rapid success.

“It’s a situation in which after the IPO (initial public offering) there were projections of such extraordinary growth,” he said. “At some point, every company goes from goals that are much higher to more moderate.”

Krispy Kreme also has been hurt by the nation’s “lifestyle changes,” in which more Americans are trying low-carb diets, Clark said.

“I think management has essentially done all they can to maintain the growth rate at high level,” he said. “In some extent, it’s a combination of a saturated market and demographics.”

AdBlock Detected!
Please disable it to support our content.
×

Related Articles

Donald Trump Presidency Updates - Politics and Government | NBC News Clone | Joe Biden Campaign News - Politics and Government | NBC News Clone | Kamala Harris Vp Announcement - Politics and Government | NBC News Clone | Trump Indictment Latest - Politics and Government | NBC News Clone | Election Results Live - Politics and Government | NBC News Clone | Swing States Polling - Politics and Government | NBC News Clone | Debate Highlights - Politics and Government | NBC News Clone | Budget Approval 2025 - Politics and Government | NBC News Clone | Abortion Ruling - Politics and Government | NBC News Clone | Us China Relations - Politics and Government | NBC News Clone | Inflation Rates 2025 Analysis - Business and Economy | NBC News Clone | Federal Reserve Interest Rates - Business and Economy | NBC News Clone | Stock Market Today - Business and Economy | NBC News Clone | Recession Prediction 2025 - Business and Economy | NBC News Clone | Jobs Report Unemployment - Business and Economy | NBC News Clone | Ai Stock Surge - Business and Economy | NBC News Clone | Housing Market Crash - Business and Economy | NBC News Clone | Oil Prices Update - Business and Economy | NBC News Clone | Amazon Prime Sales - Business and Economy | NBC News Clone | Bitcoin Etf Approval - Business and Economy | NBC News Clone | Latest Vaccine Developments - Health and Medicine | NBC News Clone | Covid Variants Update - Health and Medicine | NBC News Clone | Boosters New Guidelines - Health and Medicine | NBC News Clone | Anxiety Depression Treatment - Health and Medicine | NBC News Clone | Longevity Research - Health and Medicine | NBC News Clone | Diet Trends 2025 - Health and Medicine | NBC News Clone | Workout Routines - Health and Medicine | NBC News Clone | Fda Approvals 2025 - Health and Medicine | NBC News Clone | Ukraine Russia Conflict Updates - World News | NBC News Clone | Israel Palestine War News - World News | NBC News Clone | China Taiwan Tensions - World News | NBC News Clone | Middle East Peace Talks - World News | NBC News Clone | European Union Politics - World News | NBC News Clone | Development News - World News | NBC News Clone | North Korea Missile Test - World News | NBC News Clone | Brazil Election - World News | NBC News Clone | Openai Chatgpt News - Technology and Innovation | NBC News Clone | Google Bard Ai - Technology and Innovation | NBC News Clone | Ai Regulation Laws - Technology and Innovation | NBC News Clone | Tiktok Ban Update - Technology and Innovation | NBC News Clone | Data Breaches 2025 - Technology and Innovation | NBC News Clone | Iphone 16 Release - Technology and Innovation | NBC News Clone | Nasa Mars Mission - Technology and Innovation | NBC News Clone | Web3 Developments - Technology and Innovation | NBC News Clone | 2024 Paris Games Highlights - Sports and Recreation | NBC News Clone | Super Bowl 2025 Preview - Sports and Recreation | NBC News Clone | Nba Playoffs 2025 - Sports and Recreation | NBC News Clone | Champions League Finals - Sports and Recreation | NBC News Clone | World Series 2025 - Sports and Recreation | NBC News Clone | Masters Tournament 2025 - Sports and Recreation | NBC News Clone | Extreme Weather Events - Weather and Climate | NBC News Clone | Hurricane Season 2025 - Weather and Climate | NBC News Clone | Global Warming Report - Weather and Climate | NBC News Clone | Weekly Weather Update - Weather and Climate | NBC News Clone | Earthquake Alerts - Weather and Climate | NBC News Clone | Solar Storm Warning - Weather and Climate | NBC News Clone | Hollywood Updates - Entertainment and Celebrity | NBC News Clone | Oscar Nominations 2025 - Entertainment and Celebrity | NBC News Clone | Grammy Awards 2025 - Entertainment and Celebrity | NBC News Clone | Netflix New Releases - Entertainment and Celebrity | NBC News Clone | Video Game Releases - Entertainment and Celebrity | NBC News Clone | Bestseller List - Entertainment and Celebrity | NBC News Clone | Government Transparency - Investigations and Analysis | NBC News Clone | Political Corruption - Investigations and Analysis | NBC News Clone | Big Tech Monopoly - Investigations and Analysis | NBC News Clone | Data Privacy Scandal - Investigations and Analysis | NBC News Clone | Community Stories - Local News and Communities | NBC News Clone | Nyc Mayor News - Local News and Communities | NBC News Clone | La Wildfires Update - Local News and Communities | NBC News Clone | Hurricane Preparedness - Local News and Communities | NBC News Clone